Working… Menu
Trial record 22 of 104 for:    colon cancer | ( Map: Nebraska, United States )

A Study Evaluating Regorafenib Following Completion of Standard Chemotherapy for Patients With Colon Cancer (ARGO)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02664077
Recruitment Status : Active, not recruiting
First Posted : January 26, 2016
Last Update Posted : December 7, 2017
Information provided by (Responsible Party):
NSABP Foundation Inc

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : October 2019
Estimated Study Completion Date : October 2019